159 related articles for article (PubMed ID: 3963840)
21. Anthracycline antibiotic 2-hydroxyaclacinomycins. II. Production of 2-hydroxyaclacinomycins A and B by a new recombinant strain and their antitumor activities.
Yoshimoto A; Johdo O; Ishikura T; Takeuchi T
Jpn J Antibiot; 1991 Mar; 44(3):277-86. PubMed ID: 1880910
[TBL] [Abstract][Full Text] [Related]
22. Porothramycin, a new antibiotic of the anthramycin group: production, isolation, structure and biological activity.
Tsunakawa M; Kamei H; Konishi M; Miyaki T; Oki T; Kawaguchi H
J Antibiot (Tokyo); 1988 Oct; 41(10):1366-73. PubMed ID: 3192492
[TBL] [Abstract][Full Text] [Related]
23. [Spergualin a novel antitumor antibiotic produced by Bacillus laterosporus].
Takeuchi T
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2633-9. PubMed ID: 6508320
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic and antitumor antibiotics produced by microorganisms.
Oki T
Biotechnol Bioeng; 1980; 22 Suppl 1():83-97. PubMed ID: 6159010
[No Abstract] [Full Text] [Related]
25. [Effects of aclacinomycin B on nucleolar ultrastructure and function of RNA synthesis in human gastric cancer cells].
Li LH; Wang YS; Li GR
Zhongguo Yao Li Xue Bao; 1987 May; 8(3):266-71. PubMed ID: 2959026
[No Abstract] [Full Text] [Related]
26. A new antitumor antibiotic, spergualin: isolation and antitumor activity.
Takeuchi T; Iinuma H; Kunimoto S; Masuda T; Ishizuka M; Takeuchi M; Hamada M; Naganawa H; Kondo S; Umezawa H
J Antibiot (Tokyo); 1981 Dec; 34(12):1619-21. PubMed ID: 7333976
[No Abstract] [Full Text] [Related]
27. New antitumor antibiotics: 13-methylaclacinomycin A and its derivatives.
Soga K; Furusho H; Mori S; Oki T
J Antibiot (Tokyo); 1981 Jun; 34(6):770-3. PubMed ID: 6944303
[No Abstract] [Full Text] [Related]
28. Low-molecular-weight immunomodifiers produced by micro-organisms.
Umezawa H
Biotechnol Genet Eng Rev; 1985; 3():255-73. PubMed ID: 2936359
[No Abstract] [Full Text] [Related]
29. Enhancement of immune responses and possible inhibition of suppressor cells by aclacinomycin A.
Ishizuka M; Takeuchi T; Masuda T; Fukasawa S; Umezawa H
J Antibiot (Tokyo); 1981 Mar; 34(3):331-40. PubMed ID: 6456249
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity and permeability of the anthramycin producing organism Streptomyces refuineus to anthramycin and structurally related antibiotics.
Rokem JS; Hurley LH
J Antibiot (Tokyo); 1981 Sep; 34(9):1171-4. PubMed ID: 6895748
[TBL] [Abstract][Full Text] [Related]
31. Reduction and hydrolysis of 2-hydroxyaclacinomycin A.
Matsuzawa Y; Oki T
J Antibiot (Tokyo); 1981 Nov; 34(11):1495-7. PubMed ID: 7319910
[No Abstract] [Full Text] [Related]
32. [In vivo and in vitro antitumor activities of Aclacinomycin A made in China].
Yang JL; Han JX; Shen ZM; Lu LJ; Xu CH; Zhang HL; Wang DE; Xu SH
Yao Xue Xue Bao; 1988 May; 23(5):321-6. PubMed ID: 3213510
[No Abstract] [Full Text] [Related]
33. Antitumor activity and some pharmacologic properties of anthramycin methyl ether.
Adamson RH; Hart LG; DeVita VT; Oliverio VT
Cancer Res; 1968 Feb; 28(2):343-7. PubMed ID: 5641523
[No Abstract] [Full Text] [Related]
34. Immunosuppression as a desired pharmacological effect.
Dickneite G; Kurrle R; Seiler FR; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):250-7. PubMed ID: 6236790
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity of cyclophosphamide-treated leukaemia cells.
Kawalec M; Jakóbisiak M; Skórski T; Kawiak J
Folia Biol (Praha); 1982; 28(5):334-43. PubMed ID: 6816636
[TBL] [Abstract][Full Text] [Related]
36. Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.
Ahmed K; Turk JL
Cancer Immunol Immunother; 1989; 28(2):87-92. PubMed ID: 2783891
[TBL] [Abstract][Full Text] [Related]
37. Variation in the inhibition of restriction enzyme cleavage of lambda phage DNA produced by two covalent binding antitumor agents: anthramycin and mitomycin C.
Kaplan DJ
Biochem Biophys Res Commun; 1982 Dec; 109(3):639-48. PubMed ID: 6297483
[No Abstract] [Full Text] [Related]
38. Chemical modification of anthracycline antibiotics. V. Synthesis of 2-hydroxyaclacinomycin A by chemical glycosidation.
Tanaka H; Yoshioka T; Yoshimoto A; Shimauchi Y; Ishikura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1983 May; 36(5):601-3. PubMed ID: 6874576
[No Abstract] [Full Text] [Related]
39. Synthesis and biological activity of spergualin analogues. I.
Nishizawa R; Takei Y; Yoshida M; Tomiyoshi T; Saino T; Nishikawa K; Nemoto K; Takahashi K; Fujii A; Nakamura T
J Antibiot (Tokyo); 1988 Nov; 41(11):1629-43. PubMed ID: 3242505
[TBL] [Abstract][Full Text] [Related]
40. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
Tsuruo T
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
